For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Avedro, Inc.

USPTO Granted Patents = 54

% Expired Patents = 22.2

EPO Patents = 25

Forward Citations = 438

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Marc David Friedman (29 out of 43 patents)

David Muller (24 out of 51 patents)

Pavel Kamaev (16 out of 19 patents)

4. Mikhail Smirnov (14 out of 14 patents)

5. Desmond Christopher Adler (13 out of 42 patents)

6. David Usher (12 out of 26 patents)

7. Ronald Scharf (8 out of 8 patents)

8. Grace Elizabeth Lytle (6 out of 6 patents)

9. John Marshall (6 out of 22 patents)

10. Radha Pertaub (6 out of 6 patents)

11. Thomas Ryan (6 out of 6 patents)

12. Jun Zhang (5 out of 5 patents)

13. David C Iannetta (5 out of 5 patents)

14. Alexandra Nicklin (4 out of 4 patents)

15. Evan Sherr (4 out of 8 patents)

Core Competencies:

Corneal Cross-Linking

Photoactivation

Eye Tracking

Bioresorbable Implants

Drug Delivery

Biomechanical Properties

Mask Device

Patient-Specific Patterns

Ectatic Disorders

Therapeutic Compositions

Micro-Devices

Active Agent Monitoring

54 patents: Sort by Forward Citations

1. 12697505 - Systems and methods for applying and monitoring eye therapy (2026-08-04),

2. 12673925 - Compounds and compositions for eye treatments (2026-07-07),

3. 12636185 - Systems and methods for treating an eye with a mask device (2026-05-26),

4. 12533021 - Systems and methods for determining cross-linking distribution in a cornea and/or structural characteristics of a cornea (2026-01-27),

5. 12453652 - Systems and methods treating for corneal ectatic disorders (2025-10-28),

6. 12427062 - Systems and methods for cross-linking treatments of an eye (2025-09-30),

7. 12420072 - Systems and methods for cross-linking treatments of an eye (2025-09-23),

8. 12344598 - Bis(diazirine) derivatives as photo-crosslinker for treating corneal ectatic disorders (2025-07-01),

9. 12311025 - Formulations for eye treatments (2025-05-27),

10. 12293513 - Systems and methods for generating patient-specific corneal cross-linking treatment patterns (2025-05-06),

11. 12171691 - Systems and methods for cross-linking treatments of an eye (2024-12-24),

12. 12144546 - Systems and methods for eye tracking during eye treatment (2024-11-19),

13. 12070618 - Systems and methods for photoactivating a photosensitizer applied to an eye (2024-08-27),

14. 12042433 - Systems and methods for eye tracking during eye treatment (2024-07-23),

15. 12016794 - Photoactivation systems and methods for corneal cross-linking treatments (2024-06-25),

Avedro, Inc., based in Waltham, MA, specializes in innovative eye therapy solutions, focusing on corneal cross-linking and advanced drug delivery systems. The company is recognized for its pioneering work in photoactivation technologies and the development of bioresorbable implants that enhance the biomechanical properties of the cornea. Avedro also emphasizes patient-specific patterns and eye tracking, aiming to improve treatment outcomes in ophthalmology and provide tailored solutions for various eye conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

54 Patents

#31 in Waltham, MA

#371 in Massachusetts

#6,554 in US

#13,109 in the World

Waltham, MA, United States of America

Avedro, Inc.

Forward Citations = 438

40 inventors:

Marc David Friedman (29 out of 43 patents)

David Muller (24 out of 51 patents)

Pavel Kamaev (16 out of 19 patents)

4. Mikhail Smirnov (14 out of 14 patents)

5. Desmond Christopher Adler (13 out of 42 patents)

Please report any incorrect information to [email protected]

Loading…